The current valuation score of Avadel Pharmaceuticals PLC is 7.44, ranking 68 out of 159 in the Pharmaceuticals industry. Its current P/E ratio is -12436.78, which is -99.98% below the recent high of -2.80 and -8.87% above the recent low of -13540.23.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.